Amarin Corp Plcuk (AMRN) Interest Expenses (2015 - 2017)
Amarin Corp Plcuk (AMRN) reported Interest Expenses of $5000.0 for Q1 2017, down 95.87% year-over-year from $121000.0 in Q1 2016, and down 99.97% quarter-over-quarter from $18.3 million in Q4 2016.
Amarin Corp Plcuk (AMRN) Interest Expenses (2015 - 2017) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 3 years of Interest Expenses data on file, last reported at $5000.0 in Q1 2017.
- Interest Expenses for Q1 2017 came in at $5000.0, down 95.87% year-over-year; the trailing twelve-month figure through Dec 2017 was $5000.0 (down 99.97% YoY), and the FY2025 annual result was $7000.0, changed 0.0% from the prior year.
- Interest Expenses fell to $5000.0 in Q1 2017 per AMRN's latest filing, from $18.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $20.0 million in Q4 2015 and troughed at $5000.0 in Q1 2017.
- A 3-year average of $5.5 million and a median of $121000.0 in 2016 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2016 and 2017: Interest Expenses fell 5.47% in 2016, then tumbled 95.87% in 2017.
- A 3-year view of Interest Expenses shows it stood at $20.0 million in 2015, then dropped by 8.73% to $18.3 million in 2016, then sank by 99.97% to $5000.0 in 2017.
- Business Quant data shows AMRN's Interest Expenses at $5000.0 in Q1 2017, $18.3 million in Q4 2016, and $78000.0 in Q3 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -225.15 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 272.00 Mn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 657.00 Mn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 240.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 6.77 Bn | 6.59 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 5,000.00 |
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2016 | 18.30 Mn |
| Dec 31, 2016 | 18.30 Mn |
| Sep 30, 2016 | 78,000.00 |
| Sep 30, 2016 | 78,000.00 |
| Mar 31, 2016 | 121,000.00 |
| Mar 31, 2016 | 121,000.00 |
| Dec 31, 2015 | 20.05 Mn |
| Dec 31, 2015 | 20.05 Mn |
| Sep 30, 2015 | 102,000.00 |
| Sep 30, 2015 | 102,000.00 |
| Mar 31, 2015 | 128,000.00 |
| Mar 31, 2015 | 128,000.00 |